Andrea D Furlan
Biographic Data
| ID | 5411765 |
|---|---|
| NAME | Andrea D Furlan |
| GIVEN NAMES | Andrea D |
| FAMILY NAME | Furlan |
| SIGNATURE | FURLAN A D |
| AFFILIATIONS | University Health Network |
| ORCID | 0000-0001-6138-8510 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 1 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 1 |
Workplace and non-workplace cannabis use and the risk of workplace injury
It is important to distinguish between non-workplace and workplace use when considering workplace safety impacts of cannabis use. Findings have implications for workplace cannabis use policies and substantiate the need for worker education on the risks of workplace cannabis use
Chronic Pain and Opioid Prescribing
Clinically focused interventions for people living with pain, such as health professional education, clinical decision support systems, prescription drug monitoring programs, and multidisciplinary care to support opioid tapering, have all been promoted as important solutions to the North American opioid crisis. Yet none have so far delivered substantive beneficial opioid-related population health outcomes. In fact, while total opioid prescribing …
Warning from Canada
Aggressive pharmaceutical advertising campaigns used strategies to sell opioids that mirrored those that were once used by the tobacco industry: involvement of specialists and leaders from the field of pain medicine, overemphasis by patients' advocacy groups on pharmacotherapy for chronic non-cancer pain, loose regulatory oversight, and the treatment of healthcare as a consumer good
Workplace and non-workplace cannabis use and the risk of workplace injury
It is important to distinguish between non-workplace and workplace use when considering workplace safety impacts of cannabis use. Findings have implications for workplace cannabis use policies and substantiate the need for worker education on the risks of workplace cannabis use
Warning from Canada
Aggressive pharmaceutical advertising campaigns used strategies to sell opioids that mirrored those that were once used by the tobacco industry: involvement of specialists and leaders from the field of pain medicine, overemphasis by patients' advocacy groups on pharmacotherapy for chronic non-cancer pain, loose regulatory oversight, and the treatment of healthcare as a consumer good
Chronic Pain and Opioid Prescribing
Clinically focused interventions for people living with pain, such as health professional education, clinical decision support systems, prescription drug monitoring programs, and multidisciplinary care to support opioid tapering, have all been promoted as important solutions to the North American opioid crisis. Yet none have so far delivered substantive beneficial opioid-related population health outcomes. In fact, while total opioid prescribing …
Workplace and non-workplace cannabis use and the risk of workplace injury
It is important to distinguish between non-workplace and workplace use when considering workplace safety impacts of cannabis use. Findings have implications for workplace cannabis use policies and substantiate the need for worker education on the risks of workplace cannabis use
Medicine (2 works) · Opioid Use Disorder Treatment (2 works) · Cannabis (1 work) · Cannabis and Cannabinoid Research (1 work) · Chronic pain (1 work) · Confidence interval (1 work) · Development economics (1 work) · Economic growth (1 work) · Economics (1 work) · Environmental health (1 work)